My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Haemonetics Corporation Common Stock (NY:HAE)

50.65 -0.53 (-1.04%)
Official Closing Price Updated: 4:10 PM EDT, Sep 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,046,338
Open 51.11
Bid (Size) 46.50 (1)
Ask (Size) 52.00 (1)
Prev. Close 51.18
Today's Range 50.59 - 51.96
52wk Range 49.43 - 94.98
Shares Outstanding 51,029,618
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
9 Analysts Have This To Say About Haemonetics
 
Via Benzinga
What's Driving the Market Sentiment Around Haemonetics?
 
Via Benzinga

Performance

YTD
-35.4%
-35.4%
1 Month
-8.3%
-8.3%
3 Month
-29.7%
-29.7%
6 Month
-21.4%
-21.4%
1 Year
-33.7%
-33.7%

More News

Read More
1 Profitable Stock for Long-Term Investors and 2 That Underwhelm
Via StockStory
3 Out-of-Favor Stocks We Keep Off Our Radar
Via StockStory
Topics Firearms
Sherwin-Williams, Sealed Air, Super Micro, Globus Medical, and Haemonetics Stocks Trade Up, What You Need To Know
Via StockStory
Topics ETFs Economy
1 Russell 2000 Stock to Research Further and 2 Facing Headwinds
Via StockStory
3 Cash-Producing Stocks with Open Questions
Via StockStory
HAE Q2 Deep Dive: Margin Expansion Amid Revenue Decline and Product Execution Challenges
Via StockStory
These Analysts Slash Their Forecasts On Haemonetics After Q1 Results
Via Benzinga
Earnings Scheduled For August 7, 2025
Via Benzinga
This Trade Desk Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Via Benzinga
A Glimpse Into The Expert Outlook On Haemonetics Through 6 Analysts
Via Benzinga
Haemonetics (NYSE:HAE) Surprises With Strong Q2 But Stock Drops 24%
Via StockStory
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Haemonetics (HAE) Q1 Revenue Falls 4%
Via The Motley Fool
Peering Into Haemonetics's Recent Short Interest
Via Benzinga
Haemonetics (HAE) To Report Earnings Tomorrow: Here Is What To Expect
Via StockStory
Topics World Trade
Peering Into Haemonetics's Recent Short Interest
Via Benzinga
Lantheus, ICU Medical, Haemonetics, CONMED, and Astrana Health Shares Plummet, What You Need To Know
Via StockStory
Topics ETFs Stocks World Trade
Unpacking Q1 Earnings: Haemonetics (NYSE:HAE) In The Context Of Other Medical Devices & Supplies - Specialty Stocks
Via StockStory
1 Healthcare Stock to Target This Week and 2 to Be Wary Of
Via StockStory
Topics Stocks
3 Profitable Stocks Facing Headwinds
Via StockStory
Analyst Expectations For Haemonetics's Future
Via Benzinga
3 Russell 2000 Stocks Skating on Thin Ice
Via StockStory
Topics Economy
HAE Q1 Earnings Call: Revenue Misses Expectations, Margin Expansion and Product Focus Highlighted
Via StockStory

Frequently Asked Questions

Is Haemonetics Corporation Common Stock publicly traded?
Yes, Haemonetics Corporation Common Stock is publicly traded.
What exchange does Haemonetics Corporation Common Stock trade on?
Haemonetics Corporation Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Haemonetics Corporation Common Stock?
The ticker symbol for Haemonetics Corporation Common Stock is HAE on the New York Stock Exchange
What is the current price of Haemonetics Corporation Common Stock?
The current price of Haemonetics Corporation Common Stock is 50.65
When was Haemonetics Corporation Common Stock last traded?
The last trade of Haemonetics Corporation Common Stock was at 09/23/25 04:10 PM ET
What is the market capitalization of Haemonetics Corporation Common Stock?
The market capitalization of Haemonetics Corporation Common Stock is 2.58B
How many shares of Haemonetics Corporation Common Stock are outstanding?
Haemonetics Corporation Common Stock has 3B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.